Literature DB >> 1417486

Protective effect of anisodamine on cultured bovine pulmonary endothelial cell injury induced by oxygen-free radicals.

Z Y Luo1, Y Tang, J I You, H Luo.   

Abstract

Anisodamine, a Chinese traditional medicine herb, has been used for treatment of adult respiratory distress syndrome effectively, but little is known about its mechanism. We attempted to investigate if anisodamine could protect bovine pulmonary endothelial cell injury induced by exogenous oxygen-free radicals that were generated by xanthine/xanthine oxidase or opsonized zymosan-stimulated polymorphonuclear leukocytes. Results showed that with the addition of xanthine/xanthine oxidase into cultured bovine pulmonary endothelial cells, production of malondialdehyde and release of lactate dehydrogenase in supernatant increased, and synthesis of prostacyclin decreased. Damaged cellular membranes were revealed by scanning electron microscopy. The same was true for the addition of opsonized zymosan-stimulated polymorphonuclear leukocytes. While treatment with anisodamine greatly attenuated all of the above-mentioned parameters, results showed that (1) cultured bovine pulmonary endothelial cells could be damaged by oxygen-free radicals, (2) anisodamine had a protective effect on this injury as effective as that of superoxide dismutase and catalase, and (3) the membrane-stable action might contribute to the mechanism of protective effect against this injury.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417486     DOI: 10.1001/archsurg.1992.01420100062010

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  2 in total

Review 1.  Possible role for anisodamine in organophosphate poisoning.

Authors:  Arik Eisenkraft; Avshalom Falk
Journal:  Br J Pharmacol       Date:  2016-04-22       Impact factor: 8.739

2.  Protective effect of anisodamine in rats with glycerol-induced acute kidney injury.

Authors:  Yun-Feng Li; Bing-Yuan Xu; Ran An; Xin-Fang Du; Kun Yu; Jia-Hua Sun; Guo-Hong Zhang; Wei Wang; Li-Ping An; Guang-Li Wu
Journal:  BMC Nephrol       Date:  2019-06-17       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.